US3239503A - Azido benzenesulfonyl semicarbazides - Google Patents

Azido benzenesulfonyl semicarbazides Download PDF

Info

Publication number
US3239503A
US3239503A US218106A US21810662A US3239503A US 3239503 A US3239503 A US 3239503A US 218106 A US218106 A US 218106A US 21810662 A US21810662 A US 21810662A US 3239503 A US3239503 A US 3239503A
Authority
US
United States
Prior art keywords
benzenesulfonyl
azido
semicarbazide
grams
hydrazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US218106A
Other languages
English (en)
Inventor
Korger Gerhard
Weyer Rudi
Aumuller Walter
Haack Erich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1961F0034750 external-priority patent/DE1237120B/de
Priority claimed from DEF35063A external-priority patent/DE1262281B/de
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of US3239503A publication Critical patent/US3239503A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/28Nitrogen atoms
    • C07D295/32Nitrogen atoms acylated with carboxylic or carbonic acids, or their nitrogen or sulfur analogues
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Definitions

  • the desired compounds may be obtained from correspondingly substituted benzenesulfonyl carbamic acid halides and N,N-alkylene-hydrazines, or vice versa from N,N-alkylene-hydrazino-N'- carbonic acid halides and the corresponding benzenesulfonamides.
  • benzenesulfonyl ureas which are unsubstituted on the side of the urea molecule opposite to the sulfonyl group, or monoor disubstituted by other low molecular alkyl or aryl radicals may be converted into the desired compounds when reacted with N,N-alkylene-hydrazines per se or in the form of their salts.
  • starting materials there may be used as starting materials 0, m, p-azido or trifluoromethylbenzenesulfonic acid derivatives, such as isocyanates, amides, carbamic acid esters, ureas and thioureas.
  • the products are separated as completely as possible from the benzenesulfonamides used as starting substances or formed in the course of the reaction.
  • This separation may be favourably effected by taking up the products according to the invention in strongly diluted ammonia, filtering off any undissolvecl matter and recovering the desired products by acidification, advantageously by means of organic acids such as dilute acetic acid.
  • the 4-benzenesulf0nyl-l,1-alkylene semic-arbazides obtained according to the process of the present invention are valuable medicaments which are characterized, in particular, by a strong hypoglycemic action and very low toxicity.
  • a lowering of the blood sugar level by 30% could still be detected 24 hours after the peroral application of 4-(4-azido-benzenesulfonyl)-1,1-(- -methylpentamethylene)-semicarbazide or of 4-(4-azido-benzenesulfonyl)-l,1-hexamethylene-semicarbazide to a rabbit .sugar level by the application of an essentially smaller number of single doses.
  • medicinal preparations there enter into consideration preferably tablets containing the products of the invention and, in addition thereto, the usual adjuvants and carriers such as for example, talc, starch, lactose, tragacanth or magnesium stearate.
  • adjuvants and carriers such as for example, talc, starch, lactose, tragacanth or magnesium stearate.
  • Example 1 4-(4-azid0-benzenesulfonyl -J ,1 -hexamethylene-semicarbazide 32.4 grams of, N-(4-azido-benzenesulfonyl)-carbamic acid methyl ester were mixed with 13 grams of N,N-pentamethylene-hydrazine and heated for 30 minutes at 125 C. on the oil bath. The reaction product was then recrystallized twice from acetic ester. There was obtained the 4 (4 azido-benzenesulfonyl)-l,l-pentamethylene-semicarbazide melting at 17017l C. (with decomposition). With the meet N,N-tetramethylene-hydrazine there was obtained in an analogous manner the 4-(4-azidobenzenesulfonyl)-l,1-tetramethylene-semicarbazide.
  • hexamethylene-semicarbazide 28.3 grams of m-(trifluoromethyl-benzenesulfonyl)- carbamic acid methyl ester were mixed with 11.4 grams of N-amino-hexamethylene-imine and heated for 30 minutes at 120 C. on the oil bath. First a melt was formed which solidified subsequently. After cooling, the 4-(3-trifluoromethyl benzenesulfonyl)-1,l-hexamethylene-sermcarbazide was recrystallized, from water/ethanol and' melted at 159-16l C.
  • Example 7.'-.-4-(3-triflu0romethyl-benzenesulfonyl)-1,1- pentamethylene-semicarbazide 9.7 grams of m-(trifiuoromethyl-benzenesulfonyl)-isocyanate were dissolved .in 30cc. of absolute ether and slowly added dropwisewhile cooling and shaking-.to a solution of 5 grams of, N-amino-piperidine in about 30 cc. of absolute ether.
  • Example 8.4-(4-azido-bertzenesulfonyl)-1,1-hexamethylene-semicarbazide 24.1 grams of, N-(4-azido-benzenesulfonyl)-urea melting point 168-170 C. (prepared by reacting 4-aZidoI-ben-' 1 zenesulfonamide with potassium cyanate .in boiling aqueous ethanol) were boiled under reflux for 1 hour in 250 cc.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
US218106A 1961-08-22 1962-08-20 Azido benzenesulfonyl semicarbazides Expired - Lifetime US3239503A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1961F0034750 DE1237120B (de) 1961-08-22 1961-08-22 Verfahren zur Herstellung von 4-Benzolsulfonyl-1, 1-alkylensemicarbaziden
DEF0034822 1961-08-31
DEF35063A DE1262281B (de) 1961-10-05 1961-10-05 Verfahren zur Herstellung von 4-Benzolsulfonyl-1, 1-hexamethylensemicarbazid

Publications (1)

Publication Number Publication Date
US3239503A true US3239503A (en) 1966-03-08

Family

ID=27210235

Family Applications (1)

Application Number Title Priority Date Filing Date
US218106A Expired - Lifetime US3239503A (en) 1961-08-22 1962-08-20 Azido benzenesulfonyl semicarbazides

Country Status (6)

Country Link
US (1) US3239503A (de)
CH (3) CH438305A (de)
DK (1) DK102961C (de)
FR (3) FR2203M (de)
GB (1) GB1014424A (de)
NL (1) NL282365A (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3689649A (en) * 1970-07-16 1972-09-05 Henri Dietrich N-substituted n-arylsulfonyl ureas for producing a hypoglycaemic effect
US3939269A (en) * 1971-04-26 1976-02-17 Hoechst Aktiengesellschaft Benzenesulfon YL-semicarbazides for lowering blood sugar levels

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3015673A (en) * 1956-09-28 1962-01-02 Swiss Serum And Vaccine Inst New urea derivatives and preparation thereof
US3063903A (en) * 1961-03-29 1962-11-13 Upjohn Co Novel n-arylsulfonyl n'-(cyclicamino) ureas and oral antidiabetic compositions containing said novel compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3015673A (en) * 1956-09-28 1962-01-02 Swiss Serum And Vaccine Inst New urea derivatives and preparation thereof
US3063903A (en) * 1961-03-29 1962-11-13 Upjohn Co Novel n-arylsulfonyl n'-(cyclicamino) ureas and oral antidiabetic compositions containing said novel compounds

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3689649A (en) * 1970-07-16 1972-09-05 Henri Dietrich N-substituted n-arylsulfonyl ureas for producing a hypoglycaemic effect
US3939269A (en) * 1971-04-26 1976-02-17 Hoechst Aktiengesellschaft Benzenesulfon YL-semicarbazides for lowering blood sugar levels

Also Published As

Publication number Publication date
CH427793A (de) 1967-01-15
FR2214M (fr) 1963-12-16
NL282365A (de)
GB1014424A (en) 1965-12-22
FR2203M (fr) 1963-12-09
DK102961C (da) 1965-11-01
FR2202M (fr) 1963-12-09
CH438304A (de) 1967-06-30
CH438305A (de) 1967-06-30

Similar Documents

Publication Publication Date Title
US3668215A (en) Aryl-sulphonyl-semicarbazides containing heterocyclic acylamino groups
US3406199A (en) Benzenesulfonyl ureas and process for their manufacture
US3239503A (en) Azido benzenesulfonyl semicarbazides
US4132795A (en) Benzenesulfonyl ureas and their use for the treatment of diabetes mellitus
US3754030A (en) N - (4-(beta-<2-methoxy-5-chloro-benzamido>-ethyl) - benzenesulfonyl)-n'-cyclopentyl-urea and process for its manufacture
CA1211106A (en) Benzenesulfonyl-ureas and processes for preparing them
US3843661A (en) Benzene-sulfonyl semicarbazides
US3752818A (en) Sulphonyl ureas and sulphonyl semicarbazides containing heterocyclic acyl amino groups and their production
US3336322A (en) Benzenesulfonyl ureas and process for their manufacture
US3829434A (en) Piperidinesulfonylurea derivatives
KR880002706B1 (ko) 설포닐 우레아의 제조방법
US3449346A (en) Benzenesulfonyl ureas
US3835188A (en) Benzenesulfonyl-ureas and process for their preparation
US3454636A (en) Benzenesulfonyl-ureas and process for their manufacture
US3448149A (en) Benzenesulfonyl ureas
US3813398A (en) Benzenesulfonyl-semicarbazides and process for their manufacture
US3097240A (en) Novel sulfonyl-ureas
US3510496A (en) Benzenesulfonyl-ureas with hypoglycemic activity
US3917690A (en) Benzenesulfonyl ureas and process for their manufacture
US3607935A (en) Sulfonyl-ureas and a process for preparing them
US3435116A (en) The treatment of diabetes mellitus with benzenesulfonyl ureas
US3932658A (en) Composition and method for lower blood sugar containing N-[4-(β-<2-methoxy-5-chloro-benzamido>-ethyl)-benzenesulfonyl]-N'-cyclopentyl-urea
US3202680A (en) New benzenesulfonyl ureas and process for their manufacture
US3420882A (en) Benzenesulfonyl ureas
US3709908A (en) Benzenesulfonyl ureas having hypoglycemic activity